IS ADVANCED ALPHA-FETOPROTEIN PRODUCING GASTRIC CANCER TREATABLE?-Reference-Cited by-同舟云学术

IS ADVANCED ALPHA-FETOPROTEIN PRODUCING GASTRIC CANCER TREATABLE?

Published:2022-03-01 Issue: Volume: Page:53-54
ISSN:
Container-title:INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH
language:en
Short-container-title:ijsr

Author:

CV Kuo¹,CI Tsai²,SH Tsung³

Affiliation:

1. National Yang-Ming University, departmentof medicine, Yilan, Taiwan.

2. Chun I Tsai Medical clinic, Yilan, Taiwan.

3. Camillian St Mary's Hospital, Luodong, Yilan, Taiwan.

Abstract

We illustrated a patient with advanced alpha-fetoprotein producing gastric cancer, who was treated with chemotherapy combined with trastuzumab, resulting in complete response in four months after therapy. It has been 5 years after his initial therapy, he is now healthy and shows no evidence of tumor recurrence. The efcacy of the trastuzumab therapy in breast cancer patients prompted studies to evaluate potential clinical benet of the drug in patients with HER2 positive gastric cancer. The largest study, ToGA trial, has published a promising result leading FDA to approve the use of trastuzumab for HER2 positive gastric and gastroesophageal cancer. We discuss the need for the standardized assay method for HER2 status. We also bring attention to the existence of intratumoral heterogeneity in gastric cancer tissue which may cause false negative test for HER2 assay

Publisher

World Wide Journals

Reference9 articles.

1. Piccart-Gehart MJ., et al (2005). Trastuzumab after adjuvant chemotherapy in HER2 positive breast cancer. New England Journal Med. Springer. 353:1659-1672

2. Bang YJ.et al (2010). Traastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER-2 positive advanced gastric or gastro-esophageal junction cancer (ToGA): a phase 3 open-label randomized controlled trial. Lancet.ELSEVIER687-697.

3. Tsung, SH (2016): Alpha fetoprotein producing gastric cancer. J Formosa Med. Association.. ELSEVIER. 115:130-131.

4. Kuo CY, Tsai CI, Tsung SH (2017). Complete clinical response of a patient with advanced alpha-fetoprotein producing gastric cancer treated with chemotherapy and Trastuzumab. Gastrointestinal Cancer : Research and Therapy. (Austing Publishing group). 2(3): 1024.

5. Ogasawaraa N, Takahashib E. Matsmoto T, Amaikea M, Nagoa K, et al (2015)..Prolong survival in a case of chemotherapy sensitive gastric cancer that produced alpha-fetoproteininduced by vitamin K antagonist II. Case Rep Gastroenterol. Karger. 9:113-119.